Can Placental Corticotropin-Releasing Hormone Inform Timing of Antenatal Corticosteroid Administration?
Publication Date
2-2019
Document Type
Article
Organizational Units
College of Arts Humanities and Social Sciences, Psychology
Keywords
Corticosteroids, Placental corticotropin-releasing hormone, Antenatal
Abstract
Context
Antenatal corticosteroids are commonly administered to pregnant women at risk for delivering between 23 and 34 gestational weeks; they provide crucial benefits to fetal lung maturation and reduce risk for neonatal morbidity and mortality. Corticosteroids are maximally efficacious for lung maturation when administered within 2 to 7 days of delivery. Accurately identifying the timing of preterm delivery is thus critical to ensure that antenatal corticosteroids are administered within a week of delivery and to avoid unnecessary administration to women who will deliver at term. A plausible biomarker for predicting time of delivery is placental corticotropin-releasing hormone (pCRH).
Objective
To assess whether pCRH concentrations predict time to delivery and specifically which women will deliver within a week of treatment.
Design
pCRH concentrations were evaluated before administration of the corticosteroid betamethasone, and timing of delivery was recorded.
Participants
A total of 121 women with singleton pregnancies who were prescribed betamethasone.
Results
Elevated pCRH concentrations were associated with a shorter time from treatment to delivery. Receiver-operating characteristic curves revealed that pCRH may improve the precision of predicting preterm delivery.
Conclusions
In the current sample, pCRH concentrations predicted the likelihood of delivering within 1 week of corticosteroid treatment. Current findings suggest that pCRH may be a diagnostic indicator of impending preterm delivery. Increasing the precision in predicting time to delivery could inform when to administer antenatal corticosteroids, thus maximizing benefits and reducing the likelihood of exposing fetuses who will be delivered at term.
Copyright Date
9-11-2018
Copyright Statement / License for Reuse
All Rights Reserved.
Publication Statement
Copyright is held by the Endocrine Society. User is responsible for all copyright compliance. This article was originally published as:
Swales, D. A., Grande, L. A., Wing, D. A., Edelmann, M., Glynn, L. M, Sandman, C., . . ., & Davis, E. P. (2019). Can placental corticotropin-releasing hormone inform timing of antenatal corticosteroid administration? The Journal of Clinical Endocrinology and Metabolism, 104(2), 443-450. https://doi.org/10.1210/jc.2018-00956
Rights Holder
Endocrine Society
Provenance
Received from CHORUS
File Format
application/pdf
Language
English (eng)
Extent
8 pgs
File Size
257 KB
Publication Title
The Journal of Clinical Endocrinology and Metabolism
Volume
104
Issue
2
First Page
443
Last Page
450
ISSN
1945-7197
PubMed ID
30215731
Recommended Citation
Swales, D. A., Grande, L. A., Wing, D. A., Edelmann, M., Glynn, L. M, Sandman, C., . . ., & Davis, E. P. (2019). Can placental corticotropin-releasing hormone inform timing of antenatal corticosteroid administration? The Journal of Clinical Endocrinology and Metabolism, 104(2), 443-450. https://doi.org/10.1210/jc.2018-00956